| 22621958
|
Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet. |
Endocrinology |
2012 |
Apaijai N;Pintana H;Chattipakorn SC;Chattipakorn N |
View
More |
| 23488656
|
Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats. |
Br J Pharmacol |
2013 |
Apaijai N;Pintana H;Chattipakorn SC;Chattipakorn N |
View
More |
| 25036861
|
Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats. |
PLoS One |
2014 |
Apaijai N;Chinda K;Palee S;Chattipakorn S;Chattipakorn N |
View
More |
| 25823534
|
Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction. |
Exp Physiol |
2015 |
Inthachai T;Lekawanvijit S;Kumfu S;Apaijai N;Pongkan W;Chattipakorn SC;Chattipakorn N |
View
More |
| 27044778
|
Effects of dipeptidyl peptidase-4 inhibitor in insulin-resistant rats with myocardial infarction. |
J Endocrinol |
2016 |
Apaijai N;Inthachai T;Lekawanvijit S;Chattipakorn SC;Chattipakorn N |
View
More |
| 27875248
|
Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats. |
J Endocrinol |
2017 |
Tanajak P;Pintana H;Siri-Angkul N;Khamseekaew J;Apaijai N;Chattipakorn SC;Chattipakorn N |
View
More |
| 28391633
|
Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats. |
Cardiovasc Ther |
2017 |
Tanajak P;Sa-Nguanmoo P;Apaijai N;Wang X;Liang G;Li X;Jiang C;Chattipakorn SC;Chattipakorn N |
View
More |
